Hemolytic-Uremic Syndrome clinical trials at UCSF
1 research study open to eligible people
Hemolytic-uremic syndrome is a disease that damages the blood and kidneys. UCSF is running a trial to check the safety and effectiveness of a drug called Crovalimab in treating this illness. The study includes both adult and adolescent participants.
Showing trials for
Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
open to eligible people ages 12 years and up
This study aims to evaluate the efficacy and safety of crovalimab in adult and adolescent participants with aHUS.
San Francisco, California and other locations
Last updated: